Manfred Eigner

Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19

T. Pieber, M. Brodmann, P. Eller, 2022, Frontiers in Immunology.

Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status

W. Hörl, M. Säemann, J. Kovarik, 2013, BMC Nephrology.

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial

W. Hörl, T. Weichhart, M. Säemann, 2012, Trials.

Cell-free plasma DNA: a marker for apoptosis during hemodialysis.

K. Stuhlmeier, M. Eigner, Mathias M. Mueller, 2006, Clinical chemistry.

Optic neuropathy in uremia: an interdisciplinary emergency.

C. Leithner, W. Winkelmayer, M. Eigner, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.

M. Säemann, I. Pabinger, M. Hecking, 2020, Atherosclerosis.

Impact of Timely Public Health Measures on Kidney Transplantation in Austria during the SARS-CoV-2 Outbreak—A Nationwide Analysis

Andras T. Deak, Julia Kerschbaum, G. Mayer, 2020, Journal of clinical medicine.

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study

H. Graf, M. Eigner, A. Rosenkranz, 2011, Wiener klinische Wochenschrift.